Cystic Fibrosis (CF) Leukocyte Genes as Biomarkers for Novel Therapies
CF Leukocyte Genes as Biomarkers for Novel Therapies
Sponsor: Cystic Fibrosis Foundation
A observational or N/A phase clinical study on Cystic Fibrosis and Pulmonary Exacerbation, this trial is completed. The trial is conducted by Cystic Fibrosis Foundation and has accumulated 8 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jan 2019 — Jan 2021 [monthly]
Completed
-
Jun 2018 — Jan 2019 [monthly]
Completed
▶ Show 3 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Apr 2017 — Apr 2018 [monthly]
Completed NA
-
Jan 2017 — Apr 2017 [monthly]
Completed NA
First recorded
Feb 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Cystic Fibrosis Foundation
- National Jewish Health
For direct contact, visit the study record on ClinicalTrials.gov .